Cargando…

Microbiota and viral hepatitis: State of the art of a complex matter

Changes in gut microbiota influence both the gut and liver, which are strictly connected by the so-called “gut–liver axis”. The gut microbiota acts as a major determinant of this relationship in the onset and clinical course of liver diseases. According to the results of several studies, gut dysbios...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milosevic, Ivana, Russo, Edda, Vujovic, Ankica, Barac, Aleksandra, Stevanovic, Olja, Gitto, Stefano, Amedei, Amedeo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433613/ https://www.ncbi.nlm.nih.gov/pubmed/34588747 http://dx.doi.org/10.3748/wjg.v27.i33.5488

Ejemplares similares

Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature
por: Milosevic, Ivana, et al.
Publicado: (2019)

Diagnosis of Chronic Pulmonary Aspergillosis: Clinical, Radiological or Laboratory?
por: Barac, Aleksandra, et al.
Publicado: (2023)

Role of diet and gut microbiota on colorectal cancer immunomodulation
por: De Almeida, Carolina Vieira, et al.
Publicado: (2019)

The Impact of COVID-19 on the Profile of Hospital-Acquired Infections in Adult Intensive Care Units
por: Despotovic, Aleksa, et al.
Publicado: (2021)

Exploring the Oral Microbiome in Rheumatic Diseases, State of Art and Future Prospective in Personalized Medicine with an AI Approach
por: Bellando-Randone, Silvia, et al.
Publicado: (2021)

IL-23/IL-17 Axis in Chronic Hepatitis C and Non-Alcoholic Steatohepatitis—New Insight into Immunohepatotoxicity of Different Chronic Liver Diseases
por: Vujovic, Ankica, et al.
Publicado: (2023)

The Gut–Brain Axis in the Neuropsychological Disease Model of Obesity: A Classical Movie Revised by the Emerging Director “Microbiome”
por: Niccolai, Elena, et al.
Publicado: (2019)

Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma
por: Russo, Edda, et al.
Publicado: (2022)

Clostridioides difficile ribotype distribution in a large teaching hospital in Serbia
por: Korać, Miloš, et al.
Publicado: (2020)

Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease
por: Russo, Edda, et al.
Publicado: (2019)

Inflammatory Bowel Disease and Customized Nutritional Intervention Focusing on Gut Microbiome Balance
por: Fiorindi, Camilla, et al.
Publicado: (2022)

Editorial: The mechanism of immune cells in the development of inflammatory bowel disease (IBD) and colitis-associated colorectal cancer (CAC)
por: Russo, Edda, et al.
Publicado: (2023)

Update on Alcohol and Viral Hepatitis
por: Gitto, Stefano, et al.
Publicado: (2014)

The Gut Microbiota-Immunity Axis in ALS: A Role in Deciphering Disease Heterogeneity?
por: Niccolai, Elena, et al.
Publicado: (2021)

Exploring the food-gut axis in immunotherapy response of cancer patients
por: Russo, Edda, et al.
Publicado: (2020)

Editorial: Gut Microbiota and Inflammation: Relevance in Cancer and Cardiovascular Disease
por: Parolini, Cinzia, et al.
Publicado: (2020)

Influence of chronic liver diseases on the course and outcome of COVID-19
por: Mitrovic, Nikola, et al.
Publicado: (2023)

Circulating Metabolites Originating from Gut Microbiota Control Endothelial Cell Function
por: Amedei, Amedeo, et al.
Publicado: (2019)

I’ve Gut A Feeling: Microbiota Impacting the Conceptual and Experimental Perspectives of Personalized Medicine
por: Amedei, Amedeo, et al.
Publicado: (2018)

Microbiota shaping — the effects of probiotics, prebiotics, and fecal microbiota transplant on cognitive functions: A systematic review
por: Baldi, Simone, et al.
Publicado: (2021)

Microbiota and IPF: hidden and detected relationships
por: Fabbrizzi, Alessio, et al.
Publicado: (2021)

Microbiota, Bacterial Carbonic Anhydrases, and Modulators of Their Activity: Links to Human Diseases?
por: Amedei, Amedeo, et al.
Publicado: (2021)

Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia
por: Baldi, Simone, et al.
Publicado: (2022)

Preliminary Comparison of Oral and Intestinal Human Microbiota in Patients with Colorectal Cancer: A Pilot Study
por: Russo, Edda, et al.
Publicado: (2018)

Characterization of the “gut microbiota-immunity axis” and microbial lipid metabolites in atrophic and potential celiac disease
por: Ricci, Federica, et al.
Publicado: (2022)

Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease
por: Benucci, Maurizio, et al.
Publicado: (2022)

Art and viral hepatitis elimination programmes
por: Nima, Maryam, et al.
Publicado: (2018)

Corrigendum: Characterization of the “gut microbiota-immunity axis” and microbial lipid metabolites in atrophic and potential celiac disease
por: Ricci, Federica, et al.
Publicado: (2023)

The increasing prevalence of HIV/Helicobacter pylori co-infection over time, along with the evolution of antiretroviral therapy (ART)
por: Radovanović Spurnić, Aleksandra, et al.
Publicado: (2017)

Role of the Intestinal Microbiota in the Genesis of Major Depression and the Response to Antidepressant Drug Therapy: A Narrative Review
por: Mundula, Tiziana, et al.
Publicado: (2023)

Long-Term Follow-Up, Association between CARD15/NOD2 Polymorphisms, and Clinical Disease Behavior in Crohn's Disease Surgical Patients
por: Giudici, Francesco, et al.
Publicado: (2021)

Facial Skin Microbiome: Aging-Related Changes and Exploratory Functional Associations with Host Genetic Factors, a Pilot Study
por: Russo, Edda, et al.
Publicado: (2023)

Effects of L-NAME, a non-specific nitric oxide synthase inhibitor, on AlCl(3)-induced toxicity in the rat forebrain cortex
por: Stevanović, Ivana D., et al.
Publicado: (2009)

Correction: Benucci et al. Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease. J. Pers. Med. 2022, 12, 1174
por: Benucci, Maurizio, et al.
Publicado: (2023)

Viral Hepatitis and Hepatocellular Carcinoma: State of the Art
por: Datfar, Toofan, et al.
Publicado: (2021)

Crohn’s disease recurrence updates: first surgery vs. surgical relapse patients display different profiles of ileal microbiota and systemic microbial-associated inflammatory factors
por: Russo, Edda, et al.
Publicado: (2022)

Microbiota Transplant and Gynecological Disorders: The Bridge between Present and Future Treatments
por: Martinelli, Serena, et al.
Publicado: (2023)

Interplay between Lignans and Gut Microbiota: Nutritional, Functional and Methodological Aspects
por: Baldi, Simone, et al.
Publicado: (2023)

Fecal metabolomic profiles: A comparative study of patients with colorectal cancer vs adenomatous polyps
por: Nannini, Giulia, et al.
Publicado: (2021)

The Association of uPA, uPAR, and suPAR System with Inflammation and Joint Damage in Rheumatoid Arthritis: suPAR as a Biomarker in the Light of a Personalized Medicine Perspective
por: Benucci, Maurizio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c1damdcnt8jojfc8s2huh4da7f